Azopt Related Clinical Trials
A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin [Completed]
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Completed]
Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG) [Terminated]
Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension [Completed]
Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% [Completed]
Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs [Completed]
Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome [Completed]
Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt� 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes [Recruiting]
Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT [Terminated]
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension [Completed]
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension [Completed]
Efficacy Comparison of Xalatan and Azopt on POAG and OH [Active, not recruiting]
Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Recruiting]
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% [Completed]
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt [Completed]
Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination [Terminated]
24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol [Completed]
Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2% [Completed]
Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension [Completed]
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan [Completed]
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Completed]
Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension [Completed]
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension [Completed]
Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% [Completed]
IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy [Completed]
Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® [Completed]
Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue [Completed]
Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension [Completed]
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil [Terminated]
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America [Completed]
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) [Recruiting]
1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT [Terminated]
Stop Retinal Ganglion Cell Dysfunction Study [Recruiting]
Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy [Completed]
Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy [Completed]
AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure [Completed]
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada [Completed]
Comparison of IOP (Intraocular Pressure)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution [Recruiting]
Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma [Completed]
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Completed]
Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves [Recruiting]
Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma [Completed]
Clinical Evaluation of Patients With X-linked Retinoschisis [Active, not recruiting]
Argon Laser Peripheral Iridoplasty for Primary Angle Closure Glaucoma [Recruiting]
Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma [Recruiting]
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Completed]
Patient Preference Comparison of AZARGA Versus COSOPT [Completed]
Circadian Ocular Perfusion Pressure and Ocular Blood Flow [Completed]
The Effects of the Water Drinking Test on Intraocular Pressure [Enrolling by invitation]
ELAZOP Switching Study in Korea [Completed]
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure [Recruiting]
|
